CSL Behring Revolutionary Gene Therapy: First US Patient Receives $3.5 Million Hemophilia B Treatment

Date:

Share post:

KANKAKEE COUNTY, IL – CSL Behring has made a significant breakthrough in the treatment of hemophilia B with the FDA approval of their revolutionary gene therapy, HEMGENIX®. 

The one time dose life-changing therapy, priced at $3.5 million, offers hope and relief to individuals suffering from this severe blood disorder. By addressing the genetic cause of hemophilia B, HEMGENIX® has the potential to transform the lives of patients, significantly reducing bleeds and the need for frequent infusions. 

The first patient in the United States has already received this groundbreaking treatment this month, marking a momentous milestone in medical history. With a single infusion of HEMGENIX®, patients have experienced a remarkable reduction or elimination of the need for prophylactic treatment. 

The therapy not only offers long-term health benefits but also has the potential to generate substantial cost savings for the healthcare system. 

While the price tag of $3.5 million may seem significant, it is an investment that can provide a lifetime of freedom and relief from the burden of hemophilia B.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related articles

Midwest Storm Alert: Tornado Risk, 75+ mph Winds Expected Monday

Chicago, IL - The Midwest is on high alert as severe weather is forecasted to impact the region...

Western Michigan Braces for Severe Storm, Large Hail on Monday till 11PM

Grand Rapids, MI - Western Michigan is preparing for several rounds of strong to severe storms, forecasted to...

Indiana, Ohio Under Severe Thunderstorm Watch Until 7 PM EDT

Fort Wayne, IN - A severe thunderstorm watch has been issued for parts of Indiana and Ohio until...

Severe Weather in Joliet, Illinois: East and Central Areas Hit Hard by Storm

Joliet, IL - Large portions of the east and central areas of Joliet have sustained significant damage from...